Malondialdehyde in benign prostate hypertrophy: a useful marker?

• Main Authors: Rosaria Alba Merendino (Author), Francesco Salvo (Author), Antonella Saija (Author), Giuseppe Di Pasquale (Author), Antonio Tomaino (Author), Paola Lucia Minciullo (Author), Giuseppe Fraccica (Author), Sebastiano Gangemi (Author)
• Format: Book
• Published: Hindawi Limited, 2003-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Benign prostate hypertrophy (BPH) is the most common benign tumor in men due to obstruction of the urethra and, finally, uremia. Malondialdehyde (MDA) is a product derived from peroxidation of polyunsaturated fatty acids and related esters. Evaluation of MDA in serum represents a non-invasive biomar...